Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.458,28
0,18%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Terns Pharmaceuticals Inc (TERN) Terns Pharmaceuticals Inc (TERN) Notizie

Terns Pharmaceuticals Inc

TERN
7,09
-0,19 (-2,61%)
08 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/6/202422:10GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
30/5/202414:05GLOBETerns Pharmaceuticals to Participate in Upcoming June..
17/5/202422:05GLOBETerns Pharmaceuticals to Participate in UBS Obesity..
13/5/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202414:07EDGAR2Form 8-K - Current report
13/5/202414:05GLOBETerns Pharmaceuticals Reports First Quarter 2024 Financial..
08/5/202422:05GLOBETerns Pharmaceuticals Announces Leadership Changes
07/5/202422:05GLOBETerns Pharmaceuticals to Participate in The Citizens JMP..
03/5/202422:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
29/4/202422:05GLOBETerns Pharmaceuticals Announces Data from Ongoing Phase 1..
10/4/202422:05GLOBETerns Pharmaceuticals Appoints Melita Sun Jung as Chief..
14/3/202421:05GLOBETerns Pharmaceuticals Reports Fourth Quarter and Full Year..
11/3/202421:05GLOBETerns Pharmaceuticals Announces Orphan Drug Designation..
07/3/202422:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
06/3/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:05GLOBETerns Pharmaceuticals to Participate in Upcoming March..
16/2/202400:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/2/202414:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:20EDGAR2Form 8-K - Current report
07/2/202422:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New Chief..
07/2/202414:05GLOBETerns Pharmaceuticals Appoints Amy Burroughs as Chief..
02/2/202422:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
26/1/202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:05GLOBETerns Pharmaceuticals to Highlight 2024 Priorities and..
03/1/202422:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
29/11/202322:05GLOBETerns Pharmaceuticals to Present at the JMP Securities..
27/11/202322:05GLOBETerns Pharmaceuticals Mourns the Loss of Senthil Sundaram,..
14/11/202314:05GLOBETerns Pharmaceuticals Reports Third Quarter 2023 Financial..
13/11/202314:05GLOBETerns Pharmaceuticals Presents Late-Breaking Data from Phase..
09/11/202314:05GLOBETerns Pharmaceuticals to Participate in Upcoming November..
03/11/202321:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
02/11/202321:05GLOBETerns Pharmaceuticals Announces First Participant Dosed in..
19/10/202322:05GLOBETerns Pharmaceuticals to Participate in Upcoming Investor..
16/10/202314:05GLOBETerns Pharmaceuticals Announces Global Phase 1 Clinical..
10/10/202322:33EDGAR2Form 8-K - Current report
03/10/202322:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
06/9/202322:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
05/9/202322:05GLOBETerns Pharmaceuticals to Participate in Upcoming September..
08/8/202322:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:24EDGAR2Form 8-K - Current report
08/8/202322:15GLOBETerns Pharmaceuticals Reports Second Quarter 2023 Financial..
08/8/202322:05GLOBETerns Achieves Primary Endpoint and All Secondary Endpoints..
04/8/202300:00GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
03/8/202323:22EDGAR2Form 8-K - Current report
03/8/202323:05GLOBETerns Pharmaceuticals Announces Leadership Transition
18/7/202322:05GLOBETerns Pharmaceuticals to Host Virtual Key Opinion Leader..
05/7/202322:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
26/6/202322:05GLOBETerns Pharmaceuticals Highlights New Preclinical Data for..
Apertura: 7,11 Min: 7,06 Max: 7,5393
Chiusura: 7,28

La tua Cronologia

NASDAQ
TERN
Terns Pharmaceuticals
USOTC
ITKSF
Independent Tankers (CE)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network